Clinical studies have demonstrated that MCL-1 is often overexpressed in non-small cell lung cancer (NSCLC) [57,58], and MCL-1 overexpression together with c-Myc overexpression is correlated with poorer overall survival of patients with NSCLC [59]. The gene discussed is MYC; the disease is non-small cell lung carcinoma.